EDESA BIOTECH, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
EDESA BIOTECH, INC. (EDSA) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $6.21 million as of 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2019-08-14
- 2019-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $6.21M.
- 2019-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.77M.
- 2018-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3.21M.
- 2018-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3.86M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2019-06-30 | $6.21M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.77M 10-Q · filed 2019-08-14 |
| 2018-12-31 | $3.21M 10-Q · filed 2019-08-14 |
| 2018-06-30 | $3.86M 10-Q · filed 2019-08-14 |
| 2018-03-31 | $4.22M 10-Q · filed 2019-08-14 |
| 2017-12-31 | $5.00M 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |